Comparisons of behavioral and neurochemical characteristics between WKY, WKHA, and Wistar rat strains

Neuropsychopharmacology

Volumn 27, Issue 3, 2002, Pages 400-409

  Drolet, Guy ^a,b,c   Proulx, Karine ^a,b,c   Pearson, Debra ^a,b,c   Rochford, Joseph ^a,b,c   Deschepper, Christian F ^a,b,c  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Attention deficit; Hyperactivity; Methylphenidate; NGFI B; Prepulse inhibition

Indexed keywords

DOPAMINE; METHYLPHENIDATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; AUDITORY STIMULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; HYPERACTIVITY; IN SITU HYBRIDIZATION; LOCOMOTION; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; STARTLE REFLEX; STRAIN DIFFERENCE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; METHYLPHENIDATE; MOTOR ACTIVITY; RATS; RATS, INBRED SHR; RATS, INBRED STRAINS; RATS, INBRED WKY; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; RNA, MESSENGER; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 0036710341     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00303-2     Document Type: Article

References (38)

1. Beaudry G., Langlois M.C., Weppe I., Rouillard C., Levesque D. Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J Neurochem. 75:2000;1694-1702.
2. Bull E., Reavill C., Hagan J.J., Overend P., Jones D.N. Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder. Acquisition and performance of the DRL-60s test Behav Brain Res. 109:2000;27-35.
3. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD. Preliminary results Biol Psychiatry. 39:1996;33-41.
4. Deschepper C.F., Prescott G., Hendley E.D., Reudelhuber T.L. Genetic characterization of novel strains of rats derived from crosses between Wistar-Kyoto and spontaneously hypertensive rats, and comparisons with their parental strains. Lab Anim Sci. 47:1997;638-646.
5. Dugovic C., Solberg L.C., Redei E., Van Reeth O., Turek F.W. Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression. Neuroreport. 11:2000;627-631.
6. Dumont E.C., Rafrafi S., Laforest S., Drolet G. Involvement of central angiotensin receptors in stress adaptation. Neuroscience. 93:1999;877-884.
7. Gervais J., Soghomonian J.J., Richard D., Rouillard C. Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum. Neuroscience. 91:1999;1045-1054.
8. Hendley E.D. WKHA rats with genetic hyperactivity and hyperreactivity to stress. A review Neurosci Biobehav Rev. 24:2000;41-44.
9. Hendley E.D., Ohlsson W.G. Two new inbred rat strains derived from SHR. WKHA, hyperactive, and WKHT, hypertensive, rats Am J Physiol. 261:1991;H583-H589.
10. Kinney G.G., Wilkinson L.O., Saywell K.L., Tricklebank M.D. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J Neurosci. 19:1999;5644-5653.
11. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine. Comparison with amphetamine J Neurochem. 68:1997;2032-2037.
12. Lacroix L., Broersen L.M., Feldon J., Weiner I. Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behav Brain Res. 107:1999;111-121.
13. Langlois M., Beaudry G., Zekki H., Rouillard C., Levesque D. Impact of antipsychotic drug administration on the expression of nuclear receptors in the neocortex and striatum of the rat brain. Neuroscience. 106:2001;117-128.
14. Lopez-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology. 22:2000;191-199.
15. Lou H.C., Andresen J., Steinberg B., McLaughlin T., Friberg L. The striatum in a putative cerebral network activated by verbal awareness in normals and in ADHD children. Eur J Neurol. 5:1998;67-74.
16. Mansi J.A., Rivest S., Drolet G. Effect of immobilization stress on transcriptional activity of inducible immediate-early genes, corticotropin-releasing factor, its type 1 receptor, and enkephalin in the hypothalamus of borderline hypertensive rats. J Neurochem. 70:1998;1556-1566.
17. Mansi J.A., Laforest S., Drolet G. Effect of stress exposure on the activation pattern of enkephalin- containing perikarya in the rat ventral medulla. J Neurochem. 74:2000;2568-2575.
18. Masciotra S., Picard S., Deschepper C.F. Cosegregation analysis in genetic crosses suggests a protective role for atrial natriuretic factor against ventricular hypertrophy. Circ Res. 84:1999;1453-1458.
19. McCarty R. Stress, behavior and experimental hypertension. Neurosci Biobehav Rev. 7:1983;493-502.
20. Pare W.P. The performance of WKY rats on three tests of emotional behavior. Physiol Behav. 51:1992;1051-1056. a.
21. Pare W.P. Learning behavior, escape behavior, and depression in an ulcer susceptible rat strain. Integr Physiol Behav Sci. 27:1992;130-141. b.
22. Pare W.P. Passive-avoidance behavior in Wistar-Kyoto (WKY), Wistar, and Fischer-344 rats. Physiol Behav. 54:1993;845-852.
23. Pare W.P. Open field, learned helplessness, conditioned defensive burying, and forced-swim tests in WKY rats. Physiol Behav. 55:1994;433-439.
24. Pare W.P., Redei E. Depressive behavior and stress ulcer in Wistar Kyoto rats. J Physiol (Paris). 87:1993;229-238.
25. Pare W.P., Kluczynski J. Differences in the stress response of Wistar-Kyoto (WKY) rats from different vendors. Physiol Behav. 62:1997;643-648.
26. Pliszka S.R., McCracken J.T., Maas J.W. Catecholamines in attention-deficit hyperactivity disorder. Current perspectives J Am Acad Child Adolesc Psychiatry. 35:1996;264-272.
27. Ralph R.J., Varty G.B., Kelly M.A., Wang Y.M., Caron M.G., Rubinstein M., Grandy D.K., Low M.J., Geyer M.A. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci. 19:1999;4627-4633.
28. Sagvolden T., Hendley E.D., Knardahl S. Behavior of hypertensive and hyperactive rat strains. Hyperactivity is not unitarily determined Physiol Behav. 52:1992;49-57.
29. Sills T.L. Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window. Brain Res Bull. 48:1999;445-448.
30. Swanson J., Castellanos F.X., Murias M., LaHoste G., Kennedy J. Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol. 8:1998;263-271.
31. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry. 51:1994;139-154.
32. Tilson H.A., Chamberlain J.H., Gylys J.A., Buyniski J.P. Behavioral suppressant effects of clonidine in strains of normotensive and hypertensive rats. Eur J Pharmacol. 43:1977;99-105.
33. Vaidya C.J., Austin G., Kirkorian G., Ridlehuber H.W., Desmond J.E., Glover G.H., Gabrieli J.D. Selective effects of methylphenidate in attention deficit hyperactivity disorder. A functional magnetic resonance study Proc Natl Acad Sci USA. 95:1998;14494-14499.
34. Werme M., Olson L., Brene S. NGFI-B and nor1 mRNAs are upregulated in brain reward pathways by drugs of abuse. Different effects in Fischer and Lewis rats Mol Brain Res. 76:2000;18-24. a.
35. Werme M., Ringholm A., Olson L., Brene S. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine. Brain Res. 863:2000;112-119. b.
36. Wood G.K., Tomasiewicz H., Rutishauser U., Magnuson T., Quirion R., Rochford J., Srivastava L.K. NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle. Neuroreport. 9:1998;461-466.
37. Xiao Q., Castillo S.O., Nikodem V.M. Distribution of messenger RNAs for the orphan nuclear receptors Nurr1 and Nur77 (NGFI-B) in adult rat brain using in situ hybridization. Neuroscience. 75:1996;221-230.
38. Zetterstrom R.H., Williams R., Perlmann T., Olson L. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res Mol Brain Res. 41:1996;111-120.